Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

332 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    Success For Sanofi And Rouse

    Well known life sciences company, Sanofi and it's Chinese brand name ‘赛诺菲' are highly regarded in the Chinese market.
    ChinaIntellectual Property
    Rouse
    Rouse
  • Article

    Crossing Borders

    Partner Janet Xiao, who leads the firm's China Life Sciences Group, co-authored an article with associate Can Cui for Intellectual Property Magazine, ...
    GlobalFood, Drugs, Healthcare, Life Sciences
    Morrison Foerster
    Morrison Foerster
  • Article

    China Introduces New Medical Device GMP And GSP Rules

The CFDA expects all device companies to comply with the New GMP and GSP rules as long as they intend to sell the products in China.
ChinaFood, Drugs, Healthcare, Life Sciences
Ropes & Gray LLP
Ropes & Gray LLP
  • Article

    China Releases Vaccine Good Clinical Practices

    On October 31, 2013, The China Food and Drug Administration ("CFDA") promulgated a regulation titled Guiding Principles for the Quality Management of Clinical Studies on Vaccines ("Vaccine GCP"), with immediate effect.
    ChinaFood, Drugs, Healthcare, Life Sciences
    Ropes & Gray LLP
    Ropes & Gray LLP
  • Article

    중국쓰쵠성,지식재산권 서비스거점 20개 구축을 통한 기업 지원 강화

    쓰촨성이 중점 산업단지와 지역에 20개의 지식재산 서비스거점을 구축하여 기업 맞춤형 공공서비스를 확대하고 있다. 루저우시를 중심으로 백주, 의약건,
    ChinaIntellectual Property
    Kangxin
    Kangxin
  • Article

    北京知識産権法院、各種知財事件16万件審理 年平均20%増

    「人民法院報」の報道によると...
    ChinaIntellectual Property
    Kangxin
    Kangxin
  • Article

    China Announces Amendments to Regulation on the Supervision and Administration of Medical Devices

    On May 19, 2017, China's State Council promulgated the amendments to the 2014 Regulation on the Supervision and Administration of Medical Devices ("the Amendments"), which became effective immediately.
    ChinaFood, Drugs, Healthcare, Life Sciences
    Ropes & Gray LLP
    Ropes & Gray LLP
  • Article

    China Solicits Comments On Biosimilars Guideline

    The Center for Drug Evaluation of the China Food and Drug Administration published a long-awaited guidance document for companies seeking to develop biosimilars.
    ChinaFood, Drugs, Healthcare, Life Sciences
    Ropes & Gray LLP
    Ropes & Gray LLP
  • Article

    Chinese FDA To Launch A Quality Consistency Evaluation For Generic Drugs

    Chinese State Food and Drug Administration ("SFDA") issued a draft Work Plan for Quality Consistency Evaluation for Generic Drugs ("Work Plan") on November 22 for public comments through December 6.
    ChinaFood, Drugs, Healthcare, Life Sciences
    Ropes & Gray LLP
    Ropes & Gray LLP
  • Article

    China’s New Rules on Compulsory Licensing of Patents for Public Health

    On 29 November 2005, the State Intellectual Property Office ("SIPO") of China issued the Measures for Compulsory Licensing of Patents Concerning Public Health ("Measures").
    ChinaIntellectual Property
    Lovells
    Lovells
  • Article

    글로벌 바이오의약 산업 특허출원 순위 TOP100 발표

    2024년 10월 8일, 중국 특허 전문매체인 IPR Daily는 ‘글로벌 바이오의약 산업 특허출원 순위 TOP100'을 발표함...
    ChinaIntellectual Property
    Kangxin
    Kangxin
  • Article

    China FDA's Pharmaceutical Regulations Ready for Public Comments

    The China Food and Drug Administration (CFDA) published its proposed amendment of the Drug Administration Law (DAL) and the Drug Registration Rules (DRR) for public comments. This Alert summarizes the key changes.
    ChinaFood, Drugs, Healthcare, Life Sciences
    Ropes & Gray LLP
    Ropes & Gray LLP
  • Article

    China Unveils Detailed Rules to Implement The Core Device Regulation

    The amended Regulation for the Supervision and Administration of Medical Devices (the "Regulation," also known as the State Council Order No. 650), which came into force on June 1, 2014, set the new framework for China’s device regulatory regime.
    ChinaFood, Drugs, Healthcare, Life Sciences
    Ropes & Gray LLP
    Ropes & Gray LLP
  • Article

    Beijing IP Court Hears China's First Patent Linkage Case

    Patent linkage refers to the relationship between the market approval for a generic drug and the patent status of its branded equivalent.
    ChinaIntellectual Property
    Rouse
    Rouse
  • Article

    WIPO世界知的財産グローバル賞、中国企業6社が最終候補入り

    世界知的所有権機関(WIPO)が2026年のWIPOグローバルアワードの最終候補33社を発表し、中国企業6社が選出されて国別で最多となった。環境、健康、情&
    ChinaIntellectual Property
    Kangxin
    Kangxin
  • Article

    China's State Council Announces Major Policies to Reform the Pharmaceutical Industry

    China will launch further reforms in the pharmaceutical sector as part of the healthcare reform initiatives announced by the State Council in its February 9, 2017 Circular on Several Opinions Concerning Further Reforms of the Policies Governing Drug Production, Circulation and Usage (the "Circular No.13").
    ChinaFood, Drugs, Healthcare, Life Sciences
    Ropes & Gray LLP
    Ropes & Gray LLP
  • Article

    China Announces New Initiatives To Level The Playing Field For Innovative And Generic Drugs

    China's Government will launch several incentives to enhance accessibility of innovative drugs, especially imported oncology drugs.
    ChinaFood, Drugs, Healthcare, Life Sciences
    Ropes & Gray LLP
    Ropes & Gray LLP
  • Article

    China Issues Draft Guidance On Multi-Regional Clinical Trials

    On November 21, 2014, China Food and Drug Administration ("CFDA") released a Draft Guidance on Multi-Regional Clinical Trials (Provisional) ("Guidance") for public comments through December 21.
    ChinaFood, Drugs, Healthcare, Life Sciences
    Ropes & Gray LLP
    Ropes & Gray LLP
  • Article

    Lifesciences - A Legal guide to China (2nd edition)

    The CMS, China lifesciences team would like to introduce the 2nd edition of its legal guide to China, a 130 page guide to the lifesciences industry in China fully updated.
    ChinaFood, Drugs, Healthcare, Life Sciences
    CMS Cameron McKenna Nabarro Olswang
    CMS Cameron McKenna Nabarro Olswang
  • Article

    SFDA Requirement For Generic Pharmaceutical Re-Evaluation

    China has become the world’s largest market for generic pharmaceuticals. Generics account for more than 90% of China’s total pharmaceutical market.
    ChinaFood, Drugs, Healthcare, Life Sciences
    Clyde & Co
    Clyde & Co
  • Showing 21–40 of 332 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics